EIKO Lifesciences Complete Financial Statements
EIKO • Review detailed financials to uncover trends, confirm thesis & journal trades
6 Years of Data
2025 - 2017
Complete Financial Data Export
Export complete financial statements for EIKO Lifesciences (EIKO).
Downloads include all available records across all periods.
For market performance, see the
EIKO stock price today
.
Profitability Ratios
Net Profit Margin
8.33%
2025 data
EBITDA Margin
16.67%
2025 data
Operating Margin
15.00%
2025 data
Return on Assets
1.52%
2025 data
Return on Equity
1.75%
2025 data
Balance Sheet Ratios
Current Ratio
11.00
2025 data
Debt to Equity
1.16
2025 data
Equity Ratio
86.36%
2025 data
Asset Turnover
0.18
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+50.0%
Year-over-Year
EBITDA Growth
+100.0%
Year-over-Year
Expense Growth
+25.0%
Year-over-Year
Assets Growth
+450.0%
Year-over-Year
Equity Growth
+5600.0%
Year-over-Year
Liabilities Growth
+450.0%
Year-over-Year
Investing Cash Flow Growth
-1000.0%
Year-over-Year
Financing Cash Flow Growth
+600.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Jun 2024 | Dec 2024 | Sept 2020 | Mar 2020 | Jun 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12 | 12 | 11 | 8 | 11 | 8 | 1 | 1 | 1 | 4 | 1 | 2 | 3 | 1 | 1 | 1 |
| Expenses | 10 | 10 | 9 | 8 | 10 | 7 | 1 | 2 | 0 | 6 | 2 | 3 | 5 | 1 | 1 | 1 |
| EBITDA | 2 | 2 | 2 | 1 | 1 | 1 | 0 | -1 | 0 | -2 | 0 | 0 | -1 | 0 | 0 | 0 |
| Operating Profit Margin % | 15.00% | 12.00% | 14.00% | 5.00% | 4.00% | 9.00% | -6.00% | -148.00% | 25.00% | -44.00% | -26.00% | -18.00% | -42.00% | -14.00% | -9.00% | -14.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 2 | 2 | 0 | 1 | 1 | 0 | -1 | 0 | -2 | -1 | -1 | -2 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 0 | 0 | 0 | 0 | -1 | 0 | -1 | 0 | 0 | -1 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.78 | 0.80 | 0.66 | 0.22 | 0.29 | 0.32 | -0.14 | -1.08 | 0.17 | -1.87 | -0.58 | -0.50 | -1.55 | -0.26 | -0.25 | -0.22 |
Related Pages for EIKO Lifesciences
Additional stock information and data for EIKO
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2020 | 2019 | 2018 |
|---|---|---|---|---|
| ASSETS | ||||
| Total Assets | 66 | 12 | 9 | 11 |
| Current Assets | 33 | 5 | 4 | 6 |
| Fixed Assets | 23 | 2 | 2 | 2 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 7 | 0 | 2 | 3 |
| Other Assets | 36 | 10 | 6 | 6 |
| LIABILITIES | ||||
| Total Liabilities | 66 | 12 | 9 | 11 |
| Current Liabilities | 3 | 2 | 0 | 1 |
| Non-Current Liabilities | ||||
| SHAREHOLDERS' EQUITY | ||||
| Total Equity | 57 | 1 | 5 | 6 |
| Share Capital | 14 | 4 | 4 | 4 |
| Reserves & Surplus | 43 | -1 | 1 | 2 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2020 | March 2019 | March 2018 | March 2017 |
|---|---|---|---|---|---|
| Operating Activities | 3 | 0 | 0 | 0 | 0 |
| Investing Activities | -11 | -1 | 0 | 0 | 0 |
| Financing Activities | 7 | 1 | -1 | 0 | 0 |
| Net Cash Flow | -2 | 0 | -1 | 0 | 0 |